$189.46B
Revenue
$58.53B
Net Income
82.00%
Gross Margin
43.23%
Op. Margin
$76.03B
Free Cash Flow
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Total Revenue | $51.24B | $47.52B | $42.31B | $48.38B | $40.59B | $39.07B |
| Revenue Growth % (YoY) | 26.2% | 21.6% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $9.21B | $8.49B | $7.57B | $8.84B | $7.38B | $7.31B |
| Gross Profit | $42.04B | $39.02B | $34.74B | $39.55B | $33.21B | $31.76B |
| Gross Margin % | 82.0% | 82.1% | 82.1% | 81.7% | 81.8% | 81.3% |
| Operating Expenses | $30.71B | $27.07B | $24.76B | $25.02B | $23.24B | $24.22B |
| Research & Development | $15.14B | $12.94B | $12.15B | $12.18B | $11.18B | $10.54B |
| Operating Income | $20.54B | $20.44B | $17.55B | $23.36B | $17.35B | $14.85B |
| Operating Margin % | 40.1% | 43.0% | 41.5% | 48.3% | 42.7% | 38.0% |
| Interest Expense | $603.00M | $478.00M | $352.00M | $130.00M | $356.00M | $245.00M |
| Other Income/Expense | $1.13B | $93.00M | $827.00M | $188.00M | $472.00M | $259.00M |
| Income Before Tax | $21.66B | $20.53B | $18.38B | $23.55B | $17.82B | $15.11B |
| Income Tax Expense | $18.95B | $2.20B | $1.74B | $2.71B | $2.13B | $1.64B |
| Net Income | $2.71B | $18.34B | $16.64B | $20.84B | $15.69B | $13.46B |
| Net Margin % | 5.3% | 38.6% | 39.3% | 43.1% | 38.7% | 34.5% |
| Basic EPS | 1.08 | 7.28 | 6.59 | 8.24 | 6.20 | 5.31 |
| Diluted EPS | 1.05 | 7.14 | 6.43 | 7.98 | 6.03 | 5.16 |
| Basic Shares Outstanding | 2.52B | 2.52B | 2.53B | -2.0M | 2.53B | 2.53B |
| Diluted Shares Outstanding | 2.57B | 2.57B | 2.59B | -1.0M | 2.60B | 2.61B |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $10.19B | $12.01B | $28.75B | $43.89B | $43.85B | $32.05B |
| Short-term Investments | $34.26B | $35.07B | $41.48B | $33.93B | $27.05B | $26.04B |
| Accounts Receivable | $17.30B | $16.56B | $14.51B | $16.99B | $14.70B | $14.51B |
| Other Current Assets | $11.37B | $9.98B | $5.48B | $5.24B | $5.47B | $3.85B |
| Total Current Assets | $73.12B | $73.61B | $90.23B | $100.05B | $91.07B | $76.43B |
| Goodwill | $21.16B | $20.65B | $20.65B | $20.65B | $20.65B | $20.65B |
| Other Non-current Assets | $6.85B | $15.79B | $14.09B | $13.02B | $11.64B | $9.93B |
| Total Assets | $303.84B | $294.74B | $280.21B | $276.05B | $256.41B | $230.24B |
| Accrued Liabilities | $27.05B | $25.06B | $23.40B | $23.97B | $23.66B | $21.91B |
| Total Current Liabilities | $36.96B | $37.30B | $33.89B | $33.60B | $33.33B | $27.00B |
| Long-term Debt | $28.83B | $28.83B | $28.83B | $28.83B | $28.82B | $18.39B |
| Other Non-current Liabilities | $12.13B | $2.74B | $2.76B | $2.72B | $2.35B | $2.50B |
| Total Liabilities | $109.78B | $99.67B | $95.18B | $93.42B | $91.88B | $73.47B |
| Common Stock | - | - | - | - | - | - |
| Retained Earnings | $101.58B | $106.34B | $101.33B | $102.51B | $84.97B | $81.19B |
| Total Stockholders Equity | $194.07B | $195.07B | $185.03B | $182.64B | $164.53B | $156.76B |
| Total Liabilities & Equity | $303.84B | $294.74B | $280.21B | $276.05B | $256.41B | $230.24B |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Net Income | $2.71B | $34.98B | $16.64B | $20.84B | $41.52B | $13.46B |
| Depreciation & Amortization | $13.21B | $8.24B | $3.90B | $4.46B | $11.04B | $7.01B |
| Stock-based Compensation | $14.54B | $8.98B | $4.15B | $4.26B | $12.43B | $8.18B |
| Deferred Income Tax | $17.70B | $-2.16B | $-993.00M | - | $-3.41B | $-2.10B |
| Change in Receivables | $-660.00M | $-1.47B | $-2.80B | $2.98B | $-1.49B | $-1.35B |
| Operating Cash Flow | $79.59B | $49.59B | $24.03B | $27.99B | $63.34B | $38.62B |
| Capital Expenditure | $48.31B | $29.48B | $12.94B | $14.43B | $22.83B | $14.57B |
| Investing Cash Flow | $-67.82B | $-45.97B | $-20.01B | $-21.50B | $-25.65B | $-17.03B |
| Stock Repurchased | $26.25B | $22.92B | $12.75B | - | $30.12B | $21.31B |
| Dividends Paid | $1.33B | $1.33B | $1.33B | $1.27B | $1.26B | $2.54B |
| Financing Cash Flow | $-45.52B | $-35.47B | $-19.50B | $-5.46B | $-35.32B | $-30.95B |
| Net Change in Cash | $-33.50B | $-31.61B | $-15.37B | $311.00M | $2.30B | $-9.80B |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $51.24B | $40.59B | $141.07B | $116.12B |
| Cost of Revenue | $9.21B | $7.38B | $25.27B | $21.32B |
| Operating Expenses | $30.71B | $23.24B | $82.54B | $70.10B |
| Research & Development | $15.14B | $11.18B | $40.24B | $31.69B |
| Operating Income | $20.54B | $17.35B | $58.53B | $46.02B |
| Interest Expense | - | - | $603.00M | $356.00M |
| Other Income/Expense | $1.13B | $472.00M | $2.05B | $1.09B |
| Income Before Tax | $21.66B | $17.82B | $60.58B | $47.11B |
| Income Tax Expense | $18.95B | $2.13B | $22.89B | $5.59B |
| Net Income | $2.71B | $15.69B | $37.69B | $41.52B |
| Basic EPS | 1.08 | 6.20 | 14.96 | 16.37 |
| Diluted EPS | 1.05 | 6.03 | 14.62 | 15.88 |
| Basic Shares Outstanding | $2.52B | $2.53B | $2.52B | $2.54B |
| Diluted Shares Outstanding | $2.57B | $2.60B | $2.58B | $2.62B |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $10.19B | $43.89B |
| Short-term Investments | $34.26B | $33.93B |
| Accounts Receivable | $17.30B | $16.99B |
| Other Current Assets | $11.37B | $5.24B |
| Total Current Assets | $73.12B | $100.05B |
| Goodwill | $21.16B | $20.65B |
| Other Non-current Assets | $6.85B | $13.02B |
| Total Assets | $303.84B | $276.05B |
| Accrued Liabilities | $27.05B | $23.97B |
| Total Current Liabilities | $36.96B | $33.60B |
| Long-term Debt | $28.83B | $28.83B |
| Other Non-current Liabilities | $12.13B | $2.72B |
| Total Liabilities | $109.78B | $93.42B |
| Common Stock | - | - |
| Retained Earnings | $101.58B | $102.51B |
| Total Stockholders Equity | $194.07B | $182.64B |
| Total Liabilities & Equity | $303.84B | $276.05B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $2.71B | $15.69B | $37.69B | $41.52B |
| Depreciation & Amortization | - | - | $13.21B | $11.04B |
| Stock-based Compensation | - | - | $14.54B | $12.43B |
| Deferred Income Tax | - | - | $17.70B | $-3.41B |
| Change in Receivables | - | - | $-660.00M | $-1.49B |
| Operating Cash Flow | - | - | $79.59B | $63.34B |
| Capital Expenditure | - | - | $48.31B | $22.83B |
| Investing Cash Flow | - | - | $-67.82B | $-25.65B |
| Stock Repurchased | - | - | $26.25B | $30.12B |
| Dividends Paid | $1.33B | $1.26B | $3.99B | $3.80B |
| Financing Cash Flow | - | - | $-45.52B | $-35.32B |
| Net Change in Cash | - | - | $-33.50B | $2.30B |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.